Category

India

Daily Brief India: Latent View Analytics Ltd, Aegis Vopak Terminals Ltd, Natco Pharma, Veeda Clinical Research Ltd, Dhampur Bio Organics, HIL Ltd, Globus Spirits and more

By | Daily Briefs, India

In today’s briefing:

  • Latent View Analytics Limited: Q3 FY25 Earnings Analysis
  • Aegis Vopak Pre-IPO: Expanding Rapidly but Lots of Debt
  • Natco Pharma Q3 FY25 Earnings Analysis: 20% Lower Circuit Post Result
  • Veeda Clinical Research Ltd Pre-IPO Tearsheet
  • Dhampur Bio Organics Limited: Q3 & 9M FY25 Quarterly Update
  • HIL Limited: Q3 & 9M FY25 Earnings Analysis
  • Globus Spirits Limited Q3 FY25: Navigating Cost Pressures & Charting Future Growth


Latent View Analytics Limited: Q3 FY25 Earnings Analysis

By Nimish Maheshwari

  • Revenue rose 37.5% YoY and 9% QoQ, boosted by Decision Point contributions and a major deal win.
  • Robust growth in revenue and EBITDA underscores Latent View’s ability to secure strategic client wins, strengthening its competitive edge in data analytics.
  • Company is tracking towards its $ 100-110 Mn, where they have plan to reach upto $200 Mn in next 3 years.

Aegis Vopak Pre-IPO: Expanding Rapidly but Lots of Debt

By Nicholas Tan

  • Aegis Vopak Terminals Ltd (1902844D IN)  is looking to raise about US$415m in its upcoming India IPO.
  • Aegis Vopak (AV) is the largest Indian third-party owner and operator (in terms of storage capacity) of tank storage terminals for liquified petroleum gas (LPG) and liquid products.
  • In this note, we look at the firm’s past performance.

Natco Pharma Q3 FY25 Earnings Analysis: 20% Lower Circuit Post Result

By Sudarshan Bhandari

  • There will be significant drop in revenue in FY26 due to the loss of exclusivity of the key product, but company is looking for acquisition & doing R&D.  
  • Natco is focusing on launching the oral version of Semaglutide in the Indian market and is awaiting regulatory approvals for clinical trials.
  • Primary reason of fall in revenue was the absence of sales from a key product.

Veeda Clinical Research Ltd Pre-IPO Tearsheet

By Rosita Fernandes

  • Veeda Clinical Research Ltd (3340714Z IN)  (VCRL) is looking to raise about US$115m in its upcoming India IPO. The bookrunners for the deal are Axis, CLSA, IIFL, SBI.
  • VCRL is a global contract research organization offering comprehensive drug development services, including non-clinical, pre-clinical, clinical trials, and studies across diverse drug types like generics, biosimilars, and medical devices.
  • The company operates in key global markets, including North America, Europe, and Asia, with a presence in India.

Dhampur Bio Organics Limited: Q3 & 9M FY25 Quarterly Update

By Sudarshan Bhandari

  • Dhampur Bio Organics (DBOL IN)’ Q3 FY25 revenue surged 74.33% YoY, fueled by robust sugar and country liquor performance amid increased sales volumes.
  • The significant revenue growth indicates strong market demand and positions DBO to transition toward value-added sugar production, mitigating commodity risks.
  • Despite operational challenges and declining EBITDA margins, DBO’s strategic focus on premiumization and improved cane development underscores resilient long-term growth potential.

HIL Limited: Q3 & 9M FY25 Earnings Analysis

By Sudarshan Bhandari

  • HIL Ltd (HIL IN)‘s Q3 FY25 revenue grew modestly by 3% YoY, but EBITDA and PAT declined amid weak industry demand and sluggish pricing.
  • Lower government spending and volatile input costs underscore significant challenges in the building solutions segment, impacting overall profitability.
  • Investors should remain cautious, yet note strategic initiatives, such as distribution expansion and new product launches, offer potential for future growth.

Globus Spirits Limited Q3 FY25: Navigating Cost Pressures & Charting Future Growth

By Sudarshan Bhandari

  • Globus Spirits (GBSL IN)’ Q3 FY25 performance saw a 12.5% YoY revenue decline and significant cost pressures, while its consumer segment, especially luxury posted remarkable double-digit growth.
  • After reduction of FCI price, Company anticipate achieving margins of Rs. 5-7 per liter from ethanol, aiming for a long-term average of Rs. 7 per liter.
  • From Q4 onwards, manufacturing segment will also perform well along with growth in the consumer segment as well.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Delhivery , Action Construction Equipment, WeWork India Management Ltd, SGX Rubber Future TSR20 and more

By | Daily Briefs, India

In today’s briefing:

  • NIFTY MIDCAP150 Index Rebalance Preview: 15 Potential Changes in March
  • Action Construction Equipment Limited: Q3 FY25 Update
  • WeWork India Management Ltd Pre-IPO Tearsheet
  • Indian Trade Body Greenlights ADD On Halobutyl Rubber Imports


NIFTY MIDCAP150 Index Rebalance Preview: 15 Potential Changes in March

By Brian Freitas

  • With the review period now complete, there could be 15 changes for the NIFTY Midcap 150 Index at the March rebalance.
  • Estimated one-way turnover is 8.3% resulting in a one-way trade of INR 7.65bn (US$88m). With over US$40bn tracking the index actively, the impact on the stocks will be much larger.
  • The outright adds have outperformed the forecast deletes over the last 6 months, but there has been underperformance this calendar year.

Action Construction Equipment Limited: Q3 FY25 Update

By Sudarshan Bhandari

  • Action Construction Equipment (ACCE IN)’s Q3/9M-FY25 performance shows strong revenue growth (up 16.6% in Q3, 15.2% over nine months), improved EBITDA margins, and robust unit sales in key equipment segments.
  • Improved product mix and a focus on high-value equipment drive operational efficiency, boosting profitability amid increasing infrastructure and capital expenditure trends.
  • In the next 2 years, company will increase the proportion of exports that will drive the revenue growth.

WeWork India Management Ltd Pre-IPO Tearsheet

By Rosita Fernandes

  • WeWork India Management Ltd (1690124D IN)  (WIML) is looking to raise about US$450m in its upcoming India IPO. The bookrunners for the deal are JMFin, ICICI, Jefferies, Kotak, 360 One.
  • WIML was established in 2016 under the name, “Halosaur Bengaluru Private Limited” and is backed by Embassy Group. It is one of the leading premium flexible workspace operators.
  • WIML has been the largest operator by total revenue in the past three Fiscals, according to the CBRE Report.

Indian Trade Body Greenlights ADD On Halobutyl Rubber Imports

By Vinod Nedumudy

  • HIIR from Japan, Russia, Singapore, UK, USA face action
  • India producer Reliance Sibur petitions DGTR on dumping
  • ADD range from 10% to 70% on the affected imports

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Hexaware Technologies, Alkem Laboratories Ltd, Vishnu Chemicals and more

By | Daily Briefs, India

In today’s briefing:

  • Hexaware Technologies IPO – Not Cheap on Its Own, but Peers Are Trading a Lot Higher
  • Alkem Laboratories Ltd (ALKEM IN): Shifting Focus to Chronic Segment to Yield Result in Long-Term
  • Vishnu Chemicals Limited: Q3 FY25 Update


Hexaware Technologies IPO – Not Cheap on Its Own, but Peers Are Trading a Lot Higher

By Clarence Chu

  • Hexaware Technologies (HEXW IN) is looking to raise US$1bn from its India IPO.
  • Hexaware is a global digital and technology services company with AI at its core, delivering innovative solutions that help customers in their digital transformation journey and subsequent operations.
  • In this note, we discuss its RHP updates, undertake a peer comparison and share our thoughts on valuation.

Alkem Laboratories Ltd (ALKEM IN): Shifting Focus to Chronic Segment to Yield Result in Long-Term

By Tina Banerjee

  • Alkem Laboratories Ltd (ALKEM IN) has announced twin acquisitions in medical devices and dermatology space. The acquisitions will further strengthen Alkem’s positioning in the domestic market.
  • Alkem has reported Q3FY25 result, with mainstay domestic business showing 6% YoY growth. EBITDA margin improved to 22.5% (Q3FY24: 21.3% and Q2FY25: 22.0%).
  • Alkem’s inclination toward acute and NELM segments has been a reason for its historically cheaper valuation. However, with portfolio expansion toward high-margin chronic segment should place Alkem for re-rating.

Vishnu Chemicals Limited: Q3 FY25 Update

By Sudarshan Bhandari

  • Vishnu Chemicals (VCL IN) posted strong Q3 financials with 22% revenue, 55% EBITDA, and 66% PAT YoY growth; new capex in chromium and expansion of barium, Strontium Carbonate production underway.
  • Capacity of chromium has potential to operate at 90% utilization level, where Barium segment is operating at  60-70%, can be used till 80-85%.
  • Company is plan to gain market share in US due to reduced competition.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Oracle Financial Services, Hexaware Technologies, Borosil Renewables, Ajax Engineering Limited and more

By | Daily Briefs, India

In today’s briefing:

  • Nifty IT Index Rebalance Preview: Oracle Financial Services Could Replace L&T Tech
  • Hexaware Technologies IPO: Valuation Insights
  • The Beat Ideas: Borosil Renewables- 50% Capacity Expansion
  • Ajax Engineering IPO – Robust Growth Driven by a Comprehensive Dealer Network


Nifty IT Index Rebalance Preview: Oracle Financial Services Could Replace L&T Tech

By Brian Freitas


Hexaware Technologies IPO: Valuation Insights

By Arun George


The Beat Ideas: Borosil Renewables- 50% Capacity Expansion

By Sudarshan Bhandari

  • Borosil Renewables (BRSL IN) is India’s largest solar glass manufacturer having c apacity of 1000TPD in India and 350TPD in Germany. 
  • With the rising demand and government anti-dumping duty support company is increasing 50% capacity in India to 1500TPD in the upcoming 18 Months. 
  • Company also raised INR 700Crs of funds via preferential, 100Crs via equity from promoter and 600Crs via warrants from HNIs and family offices for capex and loan repayment.

Ajax Engineering IPO – Robust Growth Driven by a Comprehensive Dealer Network

By Akshat Shah

  • Ajax Engineering Limited (0896529D IN) is looking to raise about US$145m in its upcoming India IPO.
  • Ajax Engineering Limited (AEL) is one of the leading concrete equipment manufacturers with a comprehensive range of concrete equipment, services and solutions across the concrete application value chain.
  • In this note, we take a quick look at the company’s past performance and the IPO valuations.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Hexaware Technologies, NIFTY Index and more

By | Daily Briefs, India

In today’s briefing:

  • Hexaware Technologies IPO: The Bear Case
  • EQD | Nifty Index Options Weekly (January 20 – 24): Implied Vol Normalizes


Hexaware Technologies IPO: The Bear Case

By Arun George

  • Hexaware Technologies (HEXW IN), an Indian mid-sized global IT services company, aims to raise up to US$1.0 billion.
  • In Hexaware Technologies IPO: The Bull Case, we highlighted the key elements of the bull case. In this note, we outline the bear case.
  • The bear case rests on mid-tier revenue growth, bottom-tier margins, low offshore mix, rising unbilled receivables/contract assets and a large post-IPO share overhang.

EQD | Nifty Index Options Weekly (January 20 – 24): Implied Vol Normalizes

By John Ley

  • Implied vols adjusted downward by 3 points and now at 33rd percentile over the past year as Nifty ekes out a 40 bp gain.
  • Seasonal trends not favorable for Nifty in the 2nd half of the month.
  • Expect that vol down / spot up will re-assert itself with implied vols having normalized.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Clean Science and Technology, Sify Technologies and more

By | Daily Briefs, India

In today’s briefing:

  • Clean Science and Technologies Ltd- Entering New Habitats
  • Sify Technologies – Exploring INR3,000 Crore Data Center IPO


Clean Science and Technologies Ltd- Entering New Habitats

By Nitin Mangal

  • Clean Science and Technology (CLEAN IN) is one of the leading chemical manufacturers globally of functionally critical specialty chemicals, Pharmaceutical Intermediates, and FMCG Chemicals.
  • It has embarked on a massive expansion by commissioning a new plant to manufacture HALS and is also spending additional capex to manufacture new products.
  • With forensics, we pay attention to excessive remuneration being paid to promoters, concentration risk from top customers, and increase in attrition of permanent employees.

Sify Technologies – Exploring INR3,000 Crore Data Center IPO

By Garvit Bhandari

  • Sify Technologies Ltd is planning to tap into the burgeoning demand for data centers in the India via a INR3,000 crore IPO
  • Sify has aggressive expansion plans in place with the aim to triple its data center capacity to more than 350 MW in the coming years.
  • We expect the value of standalone data center business to be more than the current market cap of Sify. In our view, IPO will unlock value for existing Sify shareholders.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Hexaware Technologies, Sify Technologies , Deepak Fertilisers & Petro, Ganesha Ecosphere, Himadri Speciality Chemical, Kent R O Systems and more

By | Daily Briefs, India

In today’s briefing:

  • Hexaware Technologies IPO: The Bull Case
  • Sify Technologies: Unlocking Value with Data Centre IPO
  • Sify Technologies: Positive Beneficiary of the Potential IPO of Sify Infinit Spaces
  • Deepak Fertilisers Limited: Q3 FY25 Performance Analysis
  • Ganesha Ecosphere Limited: Q3 FY25 Quarterly Update
  • Himadri Speciality Chemical Ltd: Q3 & 9M FY25 Performance Analysis
  • Kent R O Systems Ltd Pre-IPO Tearsheet


Hexaware Technologies IPO: The Bull Case

By Arun George

  • Hexaware Technologies (HEXW IN), an Indian mid-sized global IT services company, aims to raise up to US$1.0 billion. 
  • BPEA privatised Hexaware in 2020. In 2021, Carlyle won an auction to acquire a 95.51% stake in Hexaware.
  • The bull case rests on sold revenue growth, reducing customer concentration, high utilization, low attrition rates, high customer satisfaction scores and top-tier cash generation.

Sify Technologies: Unlocking Value with Data Centre IPO

By Sudarshan Bhandari

  • Sify Technologies (SIFY US) is planning a Rs. 3,000 crore IPO for its data centre subsidiary, Sify Infinite Spaces, aiming to unlock significant hidden value and realign its market valuation.
  • The IPO underscores rapid growth in India’s data centre market, driven by Digital India and 5G, offering a strategic edge with lower capital costs versus global peers.
  • Investors can capitalize on a notable valuation arbitrage, as Sify’s data centre arm is vastly undervalued compared to the parent’s market cap, promising long-term upside.

Sify Technologies: Positive Beneficiary of the Potential IPO of Sify Infinit Spaces

By Douglas Kim

  • The potential IPO of Sify Infinite Spaces is likely to have a positive impact on Sify Technologies. 
  • The overall market size of data centers in India is huge and Sify Infinite Spaces certainly has the experience and capability to become one of the leaders in this segment.
  • Despite attractive market opportunity, there will be some investors that will question the overall valuation levels of Sify Infinite Spaces to justify seeking nearly 30 billion INR in the IPO. 

Deepak Fertilisers Limited: Q3 FY25 Performance Analysis

By Sudarshan Bhandari

  • Deepak Fertilisers & Petro (DFPC IN) Q3 FY25 saw revenue rise 39% YoY, EBITDA up 72%, and net profit 318% YoY, driven by expansion and a shift to specialty products.
  • Company saw significant volume growth across segments except crop nutrition segment.
  • Company is under restructuring exercise, which will demerge all the different segment and unlock value over longer term.

Ganesha Ecosphere Limited: Q3 FY25 Quarterly Update

By Sudarshan Bhandari

  • Ganesha Ecosphere (GNPL IN)’s Q3 FY25 revenue surged 39.6% YoY to ₹397.8 crores, with production volume up 22.3% YoY, and capacity expansions underway.
  • Strong revenue growth and capacity expansions enhance GEL’s market position amid rising global demand for sustainable PET recycling.
  • Investors gain confidence in GEL’s strategic shift towards high-value recycled products and international market expansion, promising long-term sustainability.

Himadri Speciality Chemical Ltd: Q3 & 9M FY25 Performance Analysis

By Sudarshan Bhandari

  • Himadri Speciality Chemical (HSCH IN) delivered strong Q3 and 9M FY25 performance, with revenue, EBITDA, and PAT rising significantly, and launched major capacity expansions and new high-value product investments.
  • Himadri is set to capitalize on growing EV and lithium-ion battery markets, enhancing long-term profitability and sustainability.
  • Company acquired Birla tyre and also took more than 10% stake in Sicona, an Australian startup specializing in silicon anode technology, which will drive further growth once stabilise.

Kent R O Systems Ltd Pre-IPO Tearsheet

By Rosita Fernandes

  • Kent R O Systems (6592700Z IN)  (KROS) is looking to raise about US$100m in its upcoming India IPO. The bookrunners for the deal are Motilal and JM Fin.
  • KROS was established in 2007. The brand ‘Kent’ is a leader in the water purifier market in India, recognized for being a pioneer in introducing reverse osmosis (RO) technology.
  • Kent’s water purifiers hold the NSF/ANSI 58 certification, an American national standard for point-of-use reverse osmosis systems, as per Technopak Report.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Bharat Petroleum Corp, Whirlpool of India, Britannia Industries, Aarti Drugs Ltd, BrainBees Solutions, Ramkrishna Forgings , Dorf-Ketal Chemicals Ltd, Euro Pratik Sales Ltd, Housing and Urban Development Corporation Limited, Aarti Industries and more

By | Daily Briefs, India

In today’s briefing:

  • Quiddity Leaderboard NIFTY Mar 25: Final Expectations; Expected DELs Could Underperform Index
  • Whirlpool of India OFS Early Look – Another Large Selldown by Parent
  • NIFTY50 Index Rebalance Preview: Adds Secure; Tight Among the Deletes
  • The Beat Ideas: Aarti Drugs Revival
  • Brainbees Solutions (FirstCry) – US$2bn IPO Lockup Expiry with Most Investors Still in the Money
  • Ramkrishna Forgings Q3 FY25 Earnings: A Mixed Bag with a Promising Outlook
  • Dorf-Ketal Chemicals India Ltd Pre-IPO Tearsheet
  • Euro Pratik Sales Ltd Pre-IPO Tearsheet
  • Hudco’s Tough Time: Lower Capex, PMAY
  • Aarti Industries Limited: Q3 FY25 Update


Quiddity Leaderboard NIFTY Mar 25: Final Expectations; Expected DELs Could Underperform Index

By Janaghan Jeyakumar, CFA

  • NIFTY 50 represents the 50 largest stocks listed in the National Stock Exchange (NSE) of India and the NIFTY Next 50 index tracks the next 50 largest names.
  • In this insight, we are presenting our final expectations for ADDs and DELs for the March 2025 index rebal event.
  • We see two changes for NIFTY 50 and four changes for NIFTY 100. We expect the results to be announced in the next few days.

Whirlpool of India OFS Early Look – Another Large Selldown by Parent

By Akshat Shah

  • Whirlpool Corp (WHR US) is looking to raise about INR 46bn (US$530m) from selling a stake of about 31% in Whirlpool of India Limited (WHIRL).
  • In an announcement released on Jan 30, 2025, the firm mentioned its ultimate parent’s intention to sell down its interest in WHIRL from 51% to 20% by mid-to-late 2025.
  • In this note, we talk about the past deal performance and other deal dynamics.

NIFTY50 Index Rebalance Preview: Adds Secure; Tight Among the Deletes

By Brian Freitas


The Beat Ideas: Aarti Drugs Revival

By Sudarshan Bhandari

  • Received US FDA Approval for both Tarapur & Baddi Facility & moving to regulated market.
  • Increase in revenues & margins with the US FDA approvals & Many products are backward integration or import substitution which is expected to boost demand
  • US entry to allow product & bottomline expansion and would also focus on increasing market presence from semi-regulated markets along with regulated markets

Brainbees Solutions (FirstCry) – US$2bn IPO Lockup Expiry with Most Investors Still in the Money

By Sumeet Singh

  • BrainBees Solutions (FIRSTCRY IN) (FirstCry) raised around US$500m in its August 2024 India IPO. The lockup on its pre-IPO investors is set to expire soon.
  • In India, FirstCry sells Mothers’, Babies’ and Kids’ products through its online platform, company-owned modern stores, franchisee-owned modern stores and general trade retail distribution.
  • In this note, we will talk about the lockup dynamics and possible placement.

Ramkrishna Forgings Q3 FY25 Earnings: A Mixed Bag with a Promising Outlook

By Sudarshan Bhandari

  • Ramkrishna Forgings (RMKF IN) reported Q3 FY25 revenue growth of 8% and volume up 13.9%, alongside new capacity expansions and Rs. 697 crore in new orders.
  • These robust results and strategic capacity boosts underscore RKFL’s resilience, positioning it for sustainable growth amid raw material and market headwinds.
  • Investors should see the mixed Q3 performance as a sign of proactive investments that could translate into significant long-term value.

Dorf-Ketal Chemicals India Ltd Pre-IPO Tearsheet

By Rosita Fernandes

  • Dorf-Ketal Chemicals Ltd (998552Z IN) (DKCIL) is looking to raise about US$579m in its upcoming India IPO. The bookrunners for the deal are JM Fin, Citi, HSBC, JPM, MS, Motilal.
  • DKCIL is an R&D with innovation-focused global manufacturer and supplier of specialty chemicals, catering to the hydrocarbons and industrial supply chains.
  • According to the F&S Report, the company is one of the major producers in the development, commercialization, and application of specialty chemicals in India.

Euro Pratik Sales Ltd Pre-IPO Tearsheet

By Rosita Fernandes

  • Euro Pratik Sales Ltd (7778885Z IN) (EPS) is looking to raise about US$100m in its upcoming India IPO. The bookrunners for the deal are Axis, Dam Capital.
  • The company operates in the decorative wall panel and decorative laminates industry as a prominent seller and marketer of Decorative Wall Panels and Decorative Laminates. 
  • According to the Technopak Report, has established itself as one of the largest organized Wall Panel brands, with a market share of 15.87% by revenue.

Hudco’s Tough Time: Lower Capex, PMAY

By Nimish Maheshwari

  • Government capex is revised to Rs. 10.2 lakh crore—8.3% below target—with significant PMAY allocation cuts amid revised funding for affordable housing projects.
  • Lower capex and reduced PMAY funds signal execution challenges in housing, potentially straining Housing and Urban Development Corporation Limited (HUDCO IN)’s growth targets despite its strong loan expansion plans.
  • Short-Term funding cuts create uncertainty, but HUDCO’s strategic focus on low-risk lending and ambitious loan targets suggests a promising long-term outlook.

Aarti Industries Limited: Q3 FY25 Update

By Sudarshan Bhandari

  • Aarti Industries (ARTO IN) reported Q3 FY25 revenue of Rs. 2,305 crores with 14% QoQ growth, robust volume gains, capacity expansions in MMA and nitro-toluene, and ongoing cost optimizations.
  • Strong Q3 performance and capacity boosts bolster AIL’s long-term growth prospects, mitigating pricing pressures and forex challenges while fueling diversification into renewables and chemical recycling.
  • AIL’s strategic investments and diverse product mix signal resilient growth and margin improvements, suggesting a promising long-term outlook despite current short-term forex volatility.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Diffusion Engineers, SK Finance Limited, Karamtara Engineering Ltd, Hexaware Technologies and more

By | Daily Briefs, India

In today’s briefing:

  • The Beat Ideas: Diffusion Ltd: A Deep Dive into a Diversified Industrial Play
  • SK Finance Ltd Pre-IPO – Strong AUM Growth Driven by Vehicle Financing
  • Karamtara Engineering Pre-IPO Tearsheet
  • Hexaware Technologies IPO: Delisted in 2020; Now Looking to Raise US$1bn


The Beat Ideas: Diffusion Ltd: A Deep Dive into a Diversified Industrial Play

By Sudarshan Bhandari

  • Diffusion Engineers (DIFFNKG IN) is expanding its value chain by integrating heavy engineering solutions, enhancing its product portfolio, and catering to diverse customer needs across core industries like cement, steel.
  • With significant investments in manufacturing facilities and a target to achieve 20% of revenue from exports, the company is set to capitalize on domestic and international market opportunities.
  • A focus on developing specialized, high-performance consumables and components positions Diffusion Engineers to meet increasing demand while reducing reliance on imports and boosting profitability.

SK Finance Ltd Pre-IPO – Strong AUM Growth Driven by Vehicle Financing

By Rosita Fernandes

  • SK Finance Limited (0893736D IN)  is planning to raise about US$260m through its upcoming India IPO.
  • SK Finance Ltd (SFL) is a non-deposit non-banking finance company middle layer (NBFC ML) operating in two main verticals, vehicle financing and financing for micro, small and medium enterprises (MSMEs).
  • As per CRISIL Report, the company was the fastest growing player in the vehicle and MSME financing segment among its peers, based on AUM growth over FY21-23.

Karamtara Engineering Pre-IPO Tearsheet

By Akshat Shah

  • Karamtara Engineering Ltd (6589452Z IN) is looking to raise about US$200m in its upcoming India IPO. The deal will be run by ICICI, IIFL, JM Fin.
  • Karamtara Engineering Limited (KEL) is a backward integrated manufacturer of products for renewable energy and transmission lines sectors.
  • According to F&S, KEL was a leading manufacturer of solar mounting structures and tracker components in India and the largest in terms of installed capacity in FY24 and 1H25.

Hexaware Technologies IPO: Delisted in 2020; Now Looking to Raise US$1bn

By Brian Freitas

  • In November 2020, HT Global IT Solutions acquired all the shares it did not own in Hexaware Technologies (HEXW IN) and delisted the stock from the NSE and BSE.
  • Now, Carlyle Group is looking to raise INR 87.5bn by selling stock at a price range of INR 674-708/share, valuing Hexaware Technologies (HEXW IN) at US$4.8bn.
  • The stock will not get Fast Entry to global indices. Inclusion at regular rebalances should take place in May and September, though the impact will be limited.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Ola Electric, Religare Enterprises, Excel Industries, Dr Agarwal’s Health Care Ltd and more

By | Daily Briefs, India

In today’s briefing:

  • Ola Electric IPO Lockup – US$1.6bn+ Lockup Release
  • The Religare Controversy: A Corporate Battle
  • The Beat Ideas: Excel Industries Ltd
  • Dr Agarwal’s Healthcare IPO Trading – Decent Anchor Demand but Subdued Overall Coverage


Ola Electric IPO Lockup – US$1.6bn+ Lockup Release

By Sumeet Singh

  • Ola Electric (OLAELEC IN) raised around US$734m in its India IPO in August 2024. The lockup for its pre-IPO investors is set to expire soon.
  • Ola Electric Mobility is a vertically integrated pure EV player in India with manufacturing capabilities for EVs and EV components, including cells
  • In this note, we will talk about the lockup dynamics and possible placement.

The Religare Controversy: A Corporate Battle

By Nimish Maheshwari

  • Religare Enterprises (RELG IN)’s saga intensifies as CEO Rashmi Saluja sues her own company amid takeover bids by the Burman family, amid insider trading allegations.
  • The battle, initially a takeover bid, has evolved into an ED probe, halting shareholder meetings and raising serious governance concerns.
  • Everything lies in the hands of Religare’s shareholder since to gain the helm again Rashmi needs more than 50% votes in the upcoming meeting on 7-Feb.

The Beat Ideas: Excel Industries Ltd

By Sudarshan Bhandari

  • Excel Industries (EXL IN) faced severe financial declines in FY24 but showed early Q2 FY25 improvement through higher export revenues and better margins amid strategic capacity expansion and new partnerships.
  • Its diversified product portfolio, especially DETC, and proactive R&D investments are key to overcoming volatility, making Excel Industries pivotal in sustaining India’s chemical innovation despite market headwinds.
  • Investors should note that despite recent downturns, targeted expansion and strategic partnerships could reverse performance trends, revealing potential long-term value if operational challenges are resolved.

Dr Agarwal’s Healthcare IPO Trading – Decent Anchor Demand but Subdued Overall Coverage

By Akshat Shah

  • Dr Agarwal’s Health Care Ltd (8140044Z IN) raised around US$350m in its India IPO.
  • Dr Agarwal’s Health Care is a healthcare/hospital chain in India providing eyecare services, including surgeries; consultations, diagnoses, non-surgical treatments; and sells opticals, contact lens, accessories and eyecare related pharmaceutical products.
  • We have looked at the company’s past performance and valuations in our previous notes. In this note, we will talk about the trading dynamics.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars